Table 3.
Reference | Number of Cohorts | Type of Mutation | Cell Type | Phenotype |
---|---|---|---|---|
[119] | 6 PD patient lines vs. 3 control lines | Exon 2–4 or 6–7 deletions | iPSC-derived DA neurons | 1. Increased Oxidative stress 2. Mitophagy impairment |
[122] | 3 PD patient lines vs. 3 control lines | Exon 3–5 or R42P deletions | iPSC-derived DA neurons | 1. Dopamine dysregulation |
[111] | 2 PD patient lines vs. 2 control lines | Exon 2–4 or Exon 6–7 deletions | iPSC-derived DA neurons | 1. Increased oxidative stress 2. Mitochondrial dysfunction 3. Increase α-synuclein aggregation |
[123] | 4 PD patient lines with 1 control line | Exon 3–4, R275W or R42P deletions | iPSC-derived DA neurons | 1. Mitochondrial dysfunction 2. Increase α-synuclein aggregation |
[124] | 1 PD patient line vs. 1 control line | Del202-203AG and IVS1+1G/A | iPSC-derived DA neurons | 1. Increased cell death |
[113] | 2 Isogenic mutated PD lines vs. 1 control line | Exon 2 deletion | iPSC-derived DA neurons | 1. Mitochondrial dysfunction |
[118] | 2 PD lines vs. 2 control lines | Exon 4 deletion | iPSC-derived DA neurons | 1. Dopamine dysregulation 2. Increased oxidative stress |
[125] | 2 PD lines vs. 2 control lines | Exon 2–4 deletion | iPSC-derived DA neurons | 1. Mitochondrial dysfunction |
[126] | 2 Isogenic mutated iPSC lines vs. 1 control line | Exon 2 deletion | iPSC-derived DA neurons | 1. Lysosomal dysfunction |
[120] | 1 PD line vs. 1 control line | Exon 5 deletion | iPSC-derived DA neurons | 1. Increase α-synuclein aggregation 2. Reduced level of anti-oxidative proteins |
[127] | 3 PD lines vs. 3 control lines | Exon 7 deletion, c.1072delT or Exon 1 deletion and c.924C>Tor c.1072delT | iPSC-derived DA neurons | 1. Mitochondrial dysfunction |
[112] | 2 PD lines vs. 2 control lines | c.1366C.T and c.1072Tdel | iPSC-derived DA neurons | 1. Dopamine dysregulation 2. Increase cell death 3. Increase α-synuclein aggregation |